These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

184 related items for PubMed ID: 28155253

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Biologic importance and prognostic significance of selected clinicopathological parameters in patients with oral and oropharyngeal squamous cell carcinoma, with emphasis on smoking, protein p16(INK4a) expression, and HPV status.
    Laco J, Nekvindova J, Novakova V, Celakovsky P, Dolezalova H, Tucek L, Vosmikova H, Vosmik M, Neskudlova T, Cermakova E, Hacova M, Sobande FA, Ryska A.
    Neoplasma; 2012; 59(4):398-408. PubMed ID: 22489695
    [Abstract] [Full Text] [Related]

  • 7. Human papillomavirus DNA and p16 expression in Japanese patients with oropharyngeal squamous cell carcinoma.
    Kawakami H, Okamoto I, Terao K, Sakai K, Suzuki M, Ueda S, Tanaka K, Kuwata K, Morita Y, Ono K, Nishio K, Nishimura Y, Doi K, Nakagawa K.
    Cancer Med; 2013 Dec; 2(6):933-41. PubMed ID: 24403267
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Transcription factor AP-1 in esophageal squamous cell carcinoma: alterations in activity and expression during human Papillomavirus infection.
    Hussain S, Bharti AC, Salam I, Bhat MA, Mir MM, Hedau S, Siddiqi MA, Basir SF, Das BC.
    BMC Cancer; 2009 Sep 16; 9():329. PubMed ID: 19758438
    [Abstract] [Full Text] [Related]

  • 11. The unveiled reality of human papillomavirus as risk factor for oral cavity squamous cell carcinoma.
    Nauta IH, Heideman DAM, Brink A, van der Steen B, Bloemena E, Koljenović S, Baatenburg de Jong RJ, Leemans CR, Brakenhoff RH.
    Int J Cancer; 2021 Jul 15; 149(2):420-430. PubMed ID: 33634865
    [Abstract] [Full Text] [Related]

  • 12. Expression of toll-like receptors in HPV-positive and HPV-negative oropharyngeal squamous cell carcinoma--an in vivo and in vitro study.
    Jouhi L, Datta N, Renkonen S, Atula T, Mäkitie A, Haglund C, Ahmed A, Syrjänen S, Grénman R, Auvinen E, Lehtonen S, Hagström J.
    Tumour Biol; 2015 Sep 15; 36(10):7755-64. PubMed ID: 25941114
    [Abstract] [Full Text] [Related]

  • 13. Risk stratification of early stage oral tongue cancers based on HPV status and p16 immunoexpression.
    Ramshankar V, Soundara VT, Shyamsundar V, Ramani P, Krishnamurthy A.
    Asian Pac J Cancer Prev; 2014 Sep 15; 15(19):8351-9. PubMed ID: 25339028
    [Abstract] [Full Text] [Related]

  • 14. p16 - a Possible Surrogate Marker for High-Risk Human Papillomaviruses in Oral Cancer?
    Sritippho T, Pongsiriwet S, Lertprasertsuke N, Buddhachat K, Sastraruji T, Iamaroon A.
    Asian Pac J Cancer Prev; 2016 Sep 15; 17(8):4049-57. PubMed ID: 27644660
    [Abstract] [Full Text] [Related]

  • 15. Constitutive activation of transcription factors NF-(kappa)B, AP-1, and NF-IL6 in human head and neck squamous cell carcinoma cell lines that express pro-inflammatory and pro-angiogenic cytokines.
    Ondrey FG, Dong G, Sunwoo J, Chen Z, Wolf JS, Crowl-Bancroft CV, Mukaida N, Van Waes C.
    Mol Carcinog; 1999 Oct 15; 26(2):119-29. PubMed ID: 10506755
    [Abstract] [Full Text] [Related]

  • 16. Low prevalence of human papillomavirus in oral cavity squamous cell carcinoma in Queensland, Australia.
    Emmett S, Jenkins G, Boros S, Whiteman DC, Panizza B, Antonsson A.
    ANZ J Surg; 2017 Sep 15; 87(9):714-719. PubMed ID: 27091484
    [Abstract] [Full Text] [Related]

  • 17. Human Papillomavirus DNA Detection by Droplet Digital PCR in Formalin-Fixed Paraffin-Embedded Tumor Tissue from Oropharyngeal Squamous Cell Carcinoma Patients.
    Schiavetto CM, de Abreu PM, von Zeidler SV, de Jesus LM, Carvalho RS, Cirino MT, Carloni AC, Oliveira C, Scapulatempo-Neto C, de Almeida GC, de Menezes NS, Carvalho AL, Reis RM, de Carvalho AC.
    Mol Diagn Ther; 2021 Jan 15; 25(1):59-70. PubMed ID: 33245553
    [Abstract] [Full Text] [Related]

  • 18. P16(INK4A) immunostaining is a strong indicator for high-risk-HPV-associated oropharyngeal carcinomas and dysplasias, but is unreliable to predict low-risk-HPV-infection in head and neck papillomas and laryngeal dysplasias.
    Mooren JJ, Gültekin SE, Straetmans JM, Haesevoets A, Peutz-Kootstra CJ, Huebbers CU, Dienes HP, Wieland U, Ramaekers FC, Kremer B, Speel EJ, Klussmann JP.
    Int J Cancer; 2014 May 01; 134(9):2108-17. PubMed ID: 24127203
    [Abstract] [Full Text] [Related]

  • 19. Verrucous carcinomas of the head and neck, including those with associated squamous cell carcinoma, lack transcriptionally active high-risk human papillomavirus.
    Patel KR, Chernock RD, Zhang TR, Wang X, El-Mofty SK, Lewis JS.
    Hum Pathol; 2013 Nov 01; 44(11):2385-92. PubMed ID: 24071016
    [Abstract] [Full Text] [Related]

  • 20. Molecular characterization of p16-immunopositive but HPV DNA-negative oropharyngeal carcinomas.
    Rietbergen MM, Snijders PJ, Beekzada D, Braakhuis BJ, Brink A, Heideman DA, Hesselink AT, Witte BI, Bloemena E, Baatenburg-De Jong RJ, Leemans CR, Brakenhoff RH.
    Int J Cancer; 2014 May 15; 134(10):2366-72. PubMed ID: 24249631
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.